 impact autolog bone marrow infus hematopoiet recoveri high-dos cyclophosphamid cisplatin potenti tumor contamin inadequaci current purg techniqu bone marrow patient solid tumor altern approach high-dos therapi autolog bone marrow abm infus level nonmyeloabl dose cyclophosphamid cvp patient metastat solid tumor patient abm no-abm nabm infus cvp impact abm hematopoiet recoveri morbid mortal patient abm underw convent chemotherapi cvp seventy-thre patient cours similar dose median day neutrophil count anc /L abm arm nabm arm level cours cours anc /L /L level abm arm anc /L compar arm incid infect durat fever similar arm mortal incid delay hematopoiet recoveri frequent nabm arm signific recoveri cours arm demonstr benefit abm cours dose level abm recoveri anc /L incid infect durat fever cvp abm patient